Fresenius Medical Care (FMS) Financials

$27.43 +1.81 (+7.05%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$27.42 -0.01 (-0.02%)

As of 05/6/2025 07:23 PM Eastern

Annual Income Statements for Fresenius Medical Care

This table shows Fresenius Medical Care's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	1,045	1,315	1,203	1,537	2,268	1,346	1,422	1,097	720	552	557
Consolidated Net Income / (Loss)	1,260	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767
Net Income / (Loss) Continuing Operations	1,513	1,315	1,223	1,867	2,547	1,614	1,754	1,380	957	810	767
Total Pre-Tax Income	1,843	1,929	2,152	2,400	3,132	2,065	2,366	1,779	1,304	1,143	1,094
Total Operating Income	2,255	2,282	2,534	2,726	2,467	2,547	2,815	2,096	1,388	1,515	1,441
Total Gross Profit	4,996	5,625	5,908	7,229	5,900	6,056	6,765	5,402	4,436	5,448	4,924
Total Revenue	16,134	16,792	17,431	21,362	18,938	19,613	21,817	19,941	20,752	21,520	20,015
Operating Revenue	16,134	16,792	17,431	21,362	18,938	19,613	21,817	19,941	20,752	21,520	20,015
Total Cost of Revenue	10,836	11,167	11,523	14,133	13,038	13,558	15,052	14,539	16,316	16,072	15,091
Total Operating Expenses	2,791	3,343	3,450	4,503	3,433	3,591	4,065	4,053	3,048	4,638	4,409
Selling, General & Admin Expense	2,644	3,204	3,296	4,370	3,302	3,403	3,828	3,803	3,392	4,381	4,219
Research & Development Expense	122	139	154	133	131	189	237	250	245	257	190
Total Other Income / (Expense), net	-411	-353	-577	-327	665	-399	-334	430	-83	333	579
Interest & Investment Income	84	114	-67	62	169	69	51	83	72	98	74
Other Income / (Expense), net	-	31	-511	112	1,010	-468	-385	347	230	235	505
Income Tax Expense	584	614	658	532	585	451	611	399	348	332	327
Net Income / (Loss) Attributable to Noncontrolling Interest	215	-	-290	-330	-279	-268	-332	-283	-236	-258	-210
Basic Earnings per Share	$3.46	$3.14	$3.74	$4.17	$6.47	$3.96	$3.96	$3.31	$2.46	$1.88	$1.89
Weighted Average Basic Shares Outstanding	306.45M	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M
Diluted Earnings per Share	-	$3.13	$3.73	$4.16	$6.45	$3.96	$3.96	$3.31	$2.46	$1.88	$1.89
Weighted Average Diluted Shares Outstanding	306.45M	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M
Weighted Average Basic & Diluted Shares Outstanding	306.45M	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M

No quarterly income statements for Fresenius Medical Care are available.

This table details how cash moves in and out of Fresenius Medical Care's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	4,263	2,387	4,864	2,366	1,336	-1,277	3,860	2,981	1,886	1,625	2,162
Net Cash From Operating Activities	1,861	2,708	2,831	2,795	2,360	3,786	5,208	2,428	2,060	2,174	2,170
Net Cash From Continuing Operating Activities	2,364	2,708	2,831	2,795	2,629	3,786	5,208	2,428	2,060	2,174	2,170
Net Income / (Loss) Continuing Operations	1,260	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767
Consolidated Net Income / (Loss)	1,260	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767
Depreciation Expense	699	704	738	883	904	1,788	2,182	1,838	1,967	1,938	1,803
Non-Cash Adjustments To Reconcile Net Income	-2.65	-150	234	21	-657	768	-562	-432	-446	-571	-534
Changes in Operating Assets and Liabilities, net	408	838	365	23	-165	-384	1,834	-358	-417	-3.06	134
Net Cash From Investing Activities	-2,691	-310	549	-680	280	-4,447	-1,601	-1,458	-773	-606	-96
Net Cash From Continuing Investing Activities	867	-310	549	-680	-315	-4,447	-1,601	-1,458	-773	-606	-96
Purchase of Property, Plant & Equipment	-932	-	-	-	-	-1,262	-1,285	-967	-775	-757	-724
Acquisitions	1,779	-310	549	-680	-	-2,493	-316	-491	-63	-39	-24
Divestitures	8.26	-	-	-	-	49	-	-	64	190	652
Net Cash From Financing Activities	805	-12	1,484	251	780	-274	254	2,012	599	57	88
Net Cash From Continuing Financing Activities	1,032	-12	1,484	251	-1,153	-274	254	2,012	599	57	88
Repayment of Debt	-187	-351	506	-429	-1,232	-3,898	-717	-30	-168	-16	0.00
Issuance of Debt	501	339	978	680	701	5,027	971	2,042	767	72	88
Cash Interest Received	-	81	47	45	-	55	51	83	72	98	70

No quarterly cash flow statements for Fresenius Medical Care are available.

This table presents Fresenius Medical Care's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	25,381	25,365	26,830	28,860	30,035	36,961	38,711	38,896	38,250	37,533	34,745
Total Current Assets	6,718	6,768	7,242	7,657	8,981	8,041	8,888	9,017	7,793	7,986	6,890
Cash & Equivalents	634	550	746	1,175	2,456	1,131	1,321	1,677	1,363	1,553	1,222
Accounts Receivable	3,397	3,503	3,893	4,206	3,926	4,018	3,963	4,042	3,974	4,023	3,528
Inventories, net	1,116	1,341	1,407	1,551	1,679	1,867	2,315	2,307	2,456	2,411	2,141
Plant, Property, & Equipment, net	3,290	3,426	3,766	4,194	4,390	4,703	4,956	4,793	4,443	4,185	3,774
Plant, Property & Equipment, gross	-	-	3,766	4,194	4,390	4,703	4,956	4,793	4,443	4,185	3,774
Total Noncurrent Assets	15,373	15,171	15,822	17,009	16,663	24,218	24,868	25,086	26,014	25,363	24,081
Long-Term Investments	677	645	629	777	744	782	930	891	828	711	643
Goodwill	13,082	13,033	13,629	14,540	13,974	15,731	15,830	16,254	16,893	16,206	15,703
Intangible Assets	869	830	845	821	780	1,601	1,687	1,652	1,625	1,507	1,418
Noncurrent Deferred & Refundable Income Taxes	141	189	307	379	396	405	429	357	335	314	238
Other Noncurrent Operating Assets	603	474	412	492	770	5,698	5,992	5,932	6,334	6,063	5,913
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	0.00	562	167
Total Liabilities & Shareholders' Equity	25,381	25,365	26,830	28,860	30,035	36,961	38,711	38,896	38,250	37,533	34,745
Total Liabilities	14,528	13,841	15,204	15,853	15,268	22,117	23,647	23,075	21,722	21,132	18,423
Total Current Liabilities	3,477	4,149	4,683	5,244	6,019	5,467	5,278	6,553	5,301	5,127	4,424
Short-Term Debt	452	793	605	924	1,596	1,315	97	1,421	694	505	2.17
Accounts Payable	714	781	883	886	910	937	1,011	971	1,018	979	1,019
Other Current Liabilities	-	-	3,195	3,434	3,324	3,214	4,170	4,161	3,589	3,643	3,403
Total Noncurrent Liabilities	11,051	9,691	10,521	10,608	9,249	16,650	18,370	16,521	16,421	16,005	13,999
Long-Term Debt	9,014	7,853	7,950	8,022	7,041	8,872	9,539	8,279	8,414	8,238	7,076
Capital Lease Obligations	-	-	-	-	0.00	5,280	5,488	5,375	5,005	4,586	4,286
Noncurrent Deferred & Payable Income Tax Liabilities	805	625	950	742	717	1,032	1,201	1,180	1,185	1,086	961
Noncurrent Employee Benefit Liabilities	642	585	539	637	632	773	878	886	550	735	702
Other Noncurrent Operating Liabilities	412	466	1,081	1,207	859	692	1,264	801	1,267	1,160	945
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	0.00	200	28
Total Equity & Noncontrolling Interests	10,028	10,496	11,626	13,269	14,766	17,175	15,064	15,821	16,528	16,401	16,322
Total Preferred & Common Equity	9,443	9,887	10,496	12,058	13,458	15,751	13,700	14,372	14,966	15,067	15,088
Total Common Equity	10,453	10,897	10,496	12,058	13,458	15,751	13,700	14,372	14,966	15,067	15,088
Common Stock	3,931	3,857	4,489	5,138	4,785	4,390	3,867	3,604	3,922	4,064	3,767
Retained Earnings	7,105	7,871	6,402	8,574	10,108	10,611	12,527	12,253	11,459	12,082	11,662
Accumulated Other Comprehensive Income / (Loss)	-1,088	-1,336	-341	-1,785	-1,378	1,166	-2,694	-1,485	-416	-1,079	-340
Noncontrolling Interest	585	609	1,129	1,211	1,309	1,425	1,364	1,449	1,562	1,334	1,234

No quarterly balance sheets for Fresenius Medical Care are available.

This table displays calculated financial ratios and metrics derived from Fresenius Medical Care's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.32%	4.08%	3.80%	22.55%	-11.35%	3.57%	11.23%	-8.60%	4.07%	3.70%	-6.99%
EBITDA Growth	1.70%	2.14%	-8.47%	34.76%	17.71%	-11.73%	19.26%	-7.17%	-16.28%	2.90%	1.68%
EBIT Growth	-0.07%	2.58%	-12.51%	40.25%	22.51%	-40.21%	16.89%	0.55%	-33.80%	8.20%	11.23%
NOPAT Growth	0.49%	0.97%	13.08%	20.59%	-5.43%	-0.75%	4.83%	-22.11%	-37.40%	5.54%	-5.94%
Net Income Growth	0.33%	4.41%	13.57%	25.00%	36.41%	-36.62%	8.65%	-21.34%	-30.66%	-15.31%	-5.35%
EPS Growth	0.00%	0.00%	19.17%	11.53%	55.05%	-38.60%	0.00%	-16.41%	-25.66%	-23.57%	0.73%
Operating Cash Flow Growth	-8.52%	45.51%	4.53%	-1.27%	-15.58%	60.45%	37.53%	-53.38%	-15.13%	5.52%	-0.20%
Free Cash Flow Firm Growth	-125.55%	701.26%	21.55%	-52.03%	94.90%	-443.88%	141.10%	-51.66%	-27.22%	169.58%	0.57%
Invested Capital Growth	10.49%	-0.17%	-0.90%	6.36%	1.01%	40.56%	-1.63%	1.41%	0.43%	-4.73%	-5.25%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.96%	33.50%	33.89%	33.84%	31.15%	30.87%	31.01%	27.09%	21.37%	25.32%	24.60%
EBITDA Margin	18.31%	17.97%	15.84%	17.42%	23.13%	19.71%	21.14%	21.47%	17.27%	17.14%	18.74%
Operating Margin	13.97%	13.59%	14.54%	12.76%	13.03%	12.99%	12.90%	10.51%	6.69%	7.04%	7.20%
EBIT Margin	13.97%	13.77%	11.61%	13.28%	18.36%	10.60%	11.14%	12.25%	7.79%	8.13%	9.72%
Profit (Net Income) Margin	7.81%	7.83%	8.57%	8.74%	13.45%	8.23%	8.04%	6.92%	4.61%	3.77%	3.83%
Tax Burden Percent	68.34%	68.18%	69.42%	77.82%	81.33%	78.17%	74.15%	77.55%	73.35%	70.90%	70.10%
Interest Burden Percent	81.76%	83.42%	106.34%	84.56%	90.09%	99.35%	97.36%	72.82%	80.65%	65.31%	56.21%
Effective Tax Rate	31.66%	31.82%	30.58%	22.18%	18.67%	21.83%	25.85%	22.45%	26.65%	29.10%	29.90%
Return on Invested Capital (ROIC)	8.51%	8.19%	9.31%	10.93%	9.98%	8.19%	7.41%	5.78%	3.58%	3.87%	3.83%
ROIC Less NNEP Spread (ROIC-NNEP)	5.01%	5.44%	5.92%	7.28%	18.87%	3.67%	4.64%	3.84%	3.09%	1.53%	1.40%
Return on Net Nonoperating Assets (RNNOA)	3.99%	4.63%	4.19%	4.07%	8.19%	1.91%	3.47%	3.16%	2.33%	1.05%	0.86%
Return on Equity (ROE)	12.50%	12.82%	13.51%	15.00%	18.17%	10.11%	10.88%	8.93%	5.92%	4.92%	4.69%
Cash Return on Invested Capital (CROIC)	-1.46%	8.36%	10.22%	4.77%	8.97%	-25.53%	9.05%	4.38%	3.16%	8.71%	9.22%
Operating Return on Assets (OROA)	9.30%	9.11%	7.75%	10.19%	11.81%	6.21%	6.42%	6.30%	4.19%	4.62%	5.39%
Return on Assets (ROA)	5.20%	5.18%	5.72%	6.71%	8.65%	4.82%	4.64%	3.56%	2.48%	2.14%	2.12%
Return on Common Equity (ROCE)	12.83%	13.33%	13.06%	13.59%	16.54%	9.24%	9.94%	8.12%	5.36%	4.49%	4.32%
Return on Equity Simple (ROE_SIMPLE)	13.34%	13.30%	14.23%	15.49%	18.93%	10.25%	12.80%	9.60%	6.39%	5.38%	5.08%
Net Operating Profit after Tax (NOPAT)	1,541	1,556	1,759	2,122	2,006	1,991	2,087	1,626	1,018	1,074	1,010
NOPAT Margin	9.55%	9.26%	10.09%	9.93%	10.59%	10.15%	9.57%	8.15%	4.90%	4.99%	5.05%
Net Nonoperating Expense Percent (NNEP)	3.50%	2.75%	3.39%	3.65%	-8.89%	4.52%	2.77%	1.94%	0.50%	2.33%	2.43%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	3.32%	3.61%	3.65%
Cost of Revenue to Revenue	67.16%	66.50%	66.11%	66.16%	68.85%	69.13%	68.99%	72.91%	78.63%	74.68%	75.40%
SG&A Expenses to Revenue	16.39%	19.08%	18.91%	20.46%	17.44%	17.35%	17.55%	19.07%	16.34%	20.36%	21.08%
R&D to Revenue	0.76%	0.83%	0.88%	0.62%	0.69%	0.96%	1.09%	1.25%	1.18%	1.19%	0.95%
Operating Expenses to Revenue	17.30%	19.91%	19.79%	21.08%	18.13%	18.31%	18.63%	20.32%	14.69%	21.55%	22.03%
Earnings before Interest and Taxes (EBIT)	2,255	2,313	2,023	2,838	3,477	2,079	2,430	2,443	1,617	1,750	1,946
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,954	3,017	2,761	3,721	4,380	3,867	4,611	4,281	3,584	3,688	3,750
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.65	0.64	0.82	0.61	0.30	0.39	0.44
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.46	0.51	0.51	0.44	0.22	0.28	0.33
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	3.83	7.48	7.90	8.01	6.29	10.76	11.93
Dividend Yield	1.69%	1.22%	1.25%	1.17%	2.19%	1.99%	1.90%	5.12%	9.87%	2.99%	2.84%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	26.09%	13.37%	12.66%	12.49%	15.89%	9.29%	8.38%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.76	0.88	0.91	0.80	0.63	0.68	0.68
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.82	1.28	1.17	1.14	0.87	0.85	0.87
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	3.53	6.48	5.52	5.31	5.03	4.97	4.63
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	4.44	12.05	10.48	9.31	11.14	10.48	8.93
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	7.70	12.58	12.20	13.99	17.70	17.07	17.20
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	6.54	6.61	4.89	9.37	8.75	8.44	8.01
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	8.56	0.00	9.99	18.45	20.08	7.58	7.14
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.94	0.82	0.74	0.67	0.58	0.90	1.00	0.95	0.85	0.81	0.70
Long-Term Debt to Equity	0.90	0.75	0.68	0.60	0.48	0.82	1.00	0.86	0.81	0.78	0.70
Financial Leverage	0.80	0.85	0.71	0.56	0.43	0.52	0.75	0.82	0.76	0.69	0.61
Leverage Ratio	2.41	2.47	2.36	2.24	2.10	2.10	2.35	2.51	2.38	2.30	2.21
Compound Leverage Factor	1.97	2.06	2.51	1.89	1.89	2.08	2.29	1.83	1.92	1.50	1.24
Debt to Total Capital	48.56%	45.17%	42.39%	40.27%	36.90%	47.38%	50.10%	48.79%	46.06%	44.84%	41.05%
Short-Term Debt to Total Capital	2.32%	4.14%	3.00%	4.16%	6.82%	4.03%	0.32%	4.60%	2.27%	1.70%	0.01%
Long-Term Debt to Total Capital	46.24%	41.03%	39.39%	36.11%	30.09%	43.36%	49.78%	44.19%	43.80%	43.14%	41.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.00%	3.18%	5.60%	5.45%	5.59%	4.36%	4.52%	4.69%	5.10%	4.49%	4.46%
Common Equity to Total Capital	53.62%	56.93%	52.01%	54.28%	57.50%	48.25%	45.38%	46.52%	48.84%	50.68%	54.50%
Debt to EBITDA	3.20	2.87	3.10	2.40	1.97	4.00	3.28	3.52	3.94	3.61	3.03
Net Debt to EBITDA	2.76	2.47	2.60	1.88	1.24	3.51	2.79	2.92	3.33	3.00	2.53
Long-Term Debt to EBITDA	3.05	2.60	2.88	2.16	1.61	3.66	3.26	3.19	3.74	3.48	3.03
Debt to NOPAT	6.14	5.56	4.86	4.22	4.30	7.77	7.25	9.27	13.87	12.41	11.25
Net Debt to NOPAT	5.29	4.79	4.08	3.30	2.71	6.81	6.17	7.69	11.72	10.30	9.40
Long-Term Debt to NOPAT	5.85	5.05	4.52	3.78	3.51	7.11	7.20	8.40	13.19	11.94	11.25
Altman Z-Score	0.00	0.00	0.00	0.00	1.94	1.47	1.62	1.47	1.30	1.44	1.53
Noncontrolling Interest Sharing Ratio	-2.66%	-4.03%	3.29%	9.40%	8.99%	8.56%	8.65%	9.11%	9.31%	8.79%	7.85%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.93	1.63	1.55	1.46	1.49	1.47	1.68	1.38	1.47	1.56	1.56
Quick Ratio	1.16	0.98	0.99	1.03	1.06	0.94	1.00	0.87	1.01	1.09	1.07
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-264	1,588	1,930	926	1,804	-6,204	2,550	1,233	897	2,419	2,432
Operating Cash Flow to CapEx	202.34%	0.00%	0.00%	0.00%	0.00%	303.07%	405.22%	251.06%	266.01%	287.08%	299.72%
Free Cash Flow to Firm to Interest Expense	-0.53	3.19	0.00	1.85	3.51	0.00	0.00	0.00	2.33	0.00	0.00
Operating Cash Flow to Interest Expense	3.76	5.44	0.00	5.59	4.60	0.00	0.00	0.00	5.35	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.90	5.44	0.00	5.59	4.72	0.00	0.00	0.00	3.34	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.66	0.67	0.77	0.64	0.59	0.58	0.51	0.54	0.57	0.55
Accounts Receivable Turnover	4.90	4.87	4.71	5.28	4.66	4.94	5.47	4.98	5.18	5.38	5.30
Inventory Turnover	9.79	9.09	8.39	9.56	8.08	7.65	7.20	6.29	6.85	6.60	6.63
Fixed Asset Turnover	5.06	5.00	4.85	5.37	4.41	4.31	4.52	4.09	4.49	4.99	5.03
Accounts Payable Turnover	15.70	14.94	13.85	15.97	14.52	14.68	15.45	14.68	16.41	16.09	15.11
Days Sales Outstanding (DSO)	74.51	74.99	77.44	69.19	78.36	73.92	66.77	73.27	70.49	67.81	68.85
Days Inventory Outstanding (DIO)	37.27	40.14	43.52	38.19	45.20	47.72	50.70	58.02	53.28	55.27	55.04
Days Payable Outstanding (DPO)	23.25	24.43	26.36	22.85	25.14	24.87	23.62	24.87	22.24	22.68	24.16
Cash Conversion Cycle (CCC)	88.53	90.71	94.60	84.53	98.42	96.78	93.85	106.42	101.53	100.40	99.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	19,008	18,976	18,806	20,002	20,204	28,399	27,936	28,330	28,450	27,106	25,684
Invested Capital Turnover	0.89	0.88	0.92	1.10	0.94	0.81	0.77	0.71	0.73	0.77	0.76
Increase / (Decrease) in Invested Capital	1,805	-32	-171	1,196	202	8,195	-462	393	121	-1,344	-1,422
Enterprise Value (EV)	0.00	0.00	0.00	0.00	15,442	25,046	25,467	22,744	18,018	18,339	17,377
Market Capitalization	0.00	0.00	0.00	0.00	8,696	10,067	11,231	8,786	4,534	5,939	6,643
Book Value per Share	$34.11	$35.69	$34.28	$39.35	$43.91	$51.33	$45.92	$49.05	$51.08	$51.35	$51.42
Tangible Book Value per Share	($11.42)	($9.71)	($12.99)	($10.78)	($4.23)	($5.15)	($12.79)	($12.06)	($12.12)	($9.02)	($6.93)
Total Capital	19,494	19,142	20,181	22,216	23,403	32,643	30,187	30,897	30,641	29,731	27,686
Total Debt	9,466	8,646	8,555	8,946	8,637	15,467	15,123	15,076	14,113	13,330	11,364
Total Long-Term Debt	9,014	7,853	7,950	8,022	7,041	14,152	15,027	13,654	13,419	12,825	11,362
Net Debt	8,155	7,452	7,180	6,994	5,437	13,554	12,872	12,508	11,923	11,066	9,500
Capital Expenditures (CapEx)	920	0.00	0.00	0.00	-62	1,249	1,285	967	775	757	724
Debt-free, Cash-free Net Working Capital (DFCFNWC)	3,059	2,862	2,418	2,162	2,102	2,758	2,385	2,208	1,823	1,811	1,247
Debt-free Net Working Capital (DFNWC)	3,693	3,412	3,164	3,337	4,557	3,889	3,707	3,885	3,185	3,364	2,468
Net Working Capital (NWC)	3,241	2,619	2,559	2,413	2,962	2,574	3,610	2,464	2,491	2,859	2,466
Net Nonoperating Expense (NNE)	281	240	265	254	-541	377	333	246	61	264	243
Net Nonoperating Obligations (NNO)	8,980	8,480	7,180	6,733	5,437	11,223	12,872	12,508	11,923	10,705	9,362
Total Depreciation and Amortization (D&A)	699	704	738	883	904	1,788	2,182	1,838	1,967	1,938	1,803
Debt-free, Cash-free Net Working Capital to Revenue	18.96%	17.04%	13.87%	10.12%	11.10%	14.06%	10.93%	11.07%	8.78%	8.42%	6.23%
Debt-free Net Working Capital to Revenue	22.89%	20.32%	18.15%	15.62%	24.06%	19.83%	16.99%	19.48%	15.35%	15.63%	12.33%
Net Working Capital to Revenue	20.09%	15.60%	14.68%	11.29%	15.64%	13.13%	16.55%	12.36%	12.01%	13.28%	12.32%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.46	$3.38	$4.07	$4.17	$6.47	$3.96	$0.00	$3.31	$2.30	$1.70	$1.89
Adjusted Weighted Average Basic Shares Outstanding	303.56M	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M
Adjusted Diluted Earnings per Share	$3.45	$0.00	$0.00	$4.16	$6.45	$3.96	$0.00	$3.31	$2.30	$1.70	$1.89
Adjusted Weighted Average Diluted Shares Outstanding	303.56M	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	303.56M	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M
Normalized Net Operating Profit after Tax (NOPAT)	1,541	1,556	1,759	2,122	2,006	1,991	2,087	1,626	1,018	1,074	1,010
Normalized NOPAT Margin	9.55%	9.26%	10.09%	9.93%	10.59%	10.15%	9.57%	8.15%	4.90%	4.99%	5.05%
Pre Tax Income Margin	11.43%	11.49%	12.34%	11.23%	16.54%	10.53%	10.84%	8.92%	6.29%	5.31%	5.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.55	4.65	0.00	5.68	6.77	0.00	0.00	0.00	4.20	0.00	0.00
NOPAT to Interest Expense	3.11	3.13	0.00	4.24	3.91	0.00	0.00	0.00	2.64	0.00	0.00
EBIT Less CapEx to Interest Expense	2.69	4.65	0.00	5.68	6.90	0.00	0.00	0.00	2.19	0.00	0.00
NOPAT Less CapEx to Interest Expense	1.25	3.13	0.00	4.24	4.03	0.00	0.00	0.00	0.63	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-45.10%	0.00%	0.00%	0.00%	14.60%	45.24%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-45.10%	0.00%	0.00%	0.00%	16.27%	86.94%	0.00%	0.00%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for Fresenius Medical Care are available.

Frequently Asked Questions About Fresenius Medical Care's Financials

When does Fresenius Medical Care's financial year end?

According to the most recent income statement we have on file, Fresenius Medical Care's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Fresenius Medical Care's net income changed over the last 10 years?

Fresenius Medical Care's net income appears to be on a downward trend, with a most recent value of $766.87 million in 2024, falling from $1.26 billion in 2014. The previous period was $810.25 million in 2023. Check out Fresenius Medical Care's forecast to explore projected trends and price targets.

What is Fresenius Medical Care's operating income?

Fresenius Medical Care's total operating income in 2024 was $1.44 billion, based on the following breakdown:

Total Gross Profit: $4.92 billion
Total Operating Expenses: $4.41 billion

How has Fresenius Medical Care revenue changed over the last 10 years?

Over the last 10 years, Fresenius Medical Care's total revenue changed from $16.13 billion in 2014 to $20.01 billion in 2024, a change of 24.1%.

How much debt does Fresenius Medical Care have?

Fresenius Medical Care's total liabilities were at $18.42 billion at the end of 2024, a 12.8% decrease from 2023, and a 26.8% increase since 2014.

How much cash does Fresenius Medical Care have?

In the past 10 years, Fresenius Medical Care's cash and equivalents has ranged from $549.50 million in 2015 to $2.46 billion in 2018, and is currently $1.22 billion as of their latest financial filing in 2024.

How has Fresenius Medical Care's book value per share changed over the last 10 years?

Over the last 10 years, Fresenius Medical Care's book value per share changed from 34.11 in 2014 to 51.42 in 2024, a change of 50.8%.

Related Companies

This page (NYSE:FMS) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care (FMS) Financials

Frequently Asked Questions About Fresenius Medical Care's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care (FMS) Financials

Annual Income Statements for Fresenius Medical Care

Quarterly Income Statements for Fresenius Medical Care

Annual Cash Flow Statements for Fresenius Medical Care

Quarterly Cash Flow Statements for Fresenius Medical Care

Annual Balance Sheets for Fresenius Medical Care

Quarterly Balance Sheets for Fresenius Medical Care

Annual Metrics and Ratios for Fresenius Medical Care

Quarterly Metrics and Ratios for Fresenius Medical Care

Frequently Asked Questions About Fresenius Medical Care's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools